Creative BioTherapeutics LLC

Creative BioTherapeutics is an emerging biotech company focusing on discovering and developing novel therapies for cancer and viruses where other options are ineffective. Founded in 2016 and headquartered in the United States, CBT's current research emphasis is on the viral mechanism of COVID-19 and the need for effective and safe treatments for late-stage disease, including late-stage COVID-19 and variants of concern. With a vision to develop and market novel, non-toxic, biologic therapies to improve the lives of patients with mid to late-stage diseases, including viruses and cancer, CBT is committed to bringing safe options to solve treatment vacuums for patients with limited hope. Their advanced technology aims to provide solutions for patients with low immune response, where vaccines and other therapies may fail. Notably, CBT received a significant $80.00K Funding Round investment on 08 February 2023. The company's dedication to delivering innovative therapies for patients with the most unmet medical needs where other therapies are ineffective demonstrates its potential as a promising investment opportunity in the biotechnology and healthcare industries.